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ABSTRACT OF DISSERTATION
Psychological Stress and High Sensitivity C-Reactive Protein Levels in
Overweight and Obese Men
by
Olivia L. Moses
Doctor of Public Health in Preventive Care
Loma Linda University, Loma Linda University, 2005
Dr. Helen Hopp Marshak, Chair
Background and Purpose. High sensitivity C-reactive protein (hs-CRP), a measure
of inflammatory response, is now considered an independent marker for coronary heart
disease. Psychological stress also affects the immune system and influences the
inflammatory response. Ladwig, et al (2003) found a significant positive association
between hs-CRP levels and depression (F=4.9, p^.008) in 726 obese males, even after
adjusting for smoking, high blood pressure and age. This study investigated if there was a
similar association between increased hs-CRP levels and psychological stress in
overweight and obese males.
Method. Sixty-one overweight (n=28) or obese (n= 33) males, ages 20-35, were
recmited to participate in a cross-sectional study. Variables assessed were body mass index
(BMI), body fat percentage, blood pressure, perceived stress using Cohen et al’s (1983)
Perceived Stress Scale (PSS), and hs-CRP blood levels.
m
Results. There was no linear association between PSS score and hs-CRP (Spearman’s
rho r=.06, p= 65). Only 11 (18.0%) subjects had hs-CRP levels above 3, the level considered to
be high risk, while almost half (n=28, 45.9%) had levels less than 1. Statistically significant
Spearman’s rho correlations were found between hs-CRP and BMI (r=.55, p=.00001), hs-CRP
and body fat percentage (r=.59, p^.OOOOOl), and a trend for perceived stress score and BMI
(r=.23, p=.07). Levels of hs-CRP were higher in obese than overweight subjects (mean = 2.7 vs
0.9, p=.00003).
Conclusion. This study confirmed an association of hs-CRP with BMI and body fat but
showed no linear relationship of chronic stress of daily life to hs-CRP levels.
Importance to Preventive Care. Although this study did not find an association
between chronic stress and hs-CRP, previous research indicates that acute stressors do play a
role in increasing this measure of inflammatory response. Preventive care specialists need to
consider reducing obesity and possibly accounting for acute, rather than chronic, stressors
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A. Statement of the Problem
The rate of overweight and obese individuals has been increasing at a phenomenal
rate over the last two decades. According to the Centers for Disease Control and
Prevention (CDCP) (2003), the percentage of obese adults has increased from 12.0% in
1991 to 20.9% in 2001. Results from the National Health and Nutrition Examination
Survey (NHANES) show that in 1999-2000, an estimated 64% of U.S. adults were either
overweight or obese (CDCP, 2004). This translates into millions of people suffering
from extra weight and the many health consequences that overweight and obesity
produce. It is estimated that in 2002, national costs attributed to both overweight and
obesity accounted for medical expenditures of $9.2 billion (Centers for Disease Control
and Prevention, 2002). The United States is experiencing an overweight and obesity
epidemic that warrants special attention.
Heart disease, whether it is called coronary artery disease (CAD) or
cardiovascular disease (CVD), is another negative health condition that can have
devastating effects on well-being. Heart disease is one of the many health consequences
associated with overweight and obesity (Hiroshi, et al., 2004; Matsuzawa, Shimomura,
Kihara & Funahashi, 2003; Watkins, 2004). Currently, CAD is one of the leading causes
of death in the United States with nearly 40% of all deaths associated with heart disease
and stroke. Over 930,000 Americans die of cardiovascular disease a year which
translates into one death every 34 seconds (CDCP, 2004). Despite the use of new
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pharmacologic and lifestyle approaches to lower plasma cholesterol concentrations,
cardiovascular disease continues to be the main cause of death in the United States,
Europe, and much of Asia (Ross, 1999).
Lifestyle interventions and prevention strategies are a vital aspect of CAD
treatment and prevention as well as other diseases such as diabetes (Mosca, 2002; Sahay
& Sahay, 2002; Sdringola, et al, 2003). Lifestyle changes such as improving diet, weight
loss and smoking cessation lowers disease risk. Therefore these strategies have been the
major focus of prevention interventions.
Stress reduction is likely to become another major target for lifestyle intervention
of CAD in the future. Studies show that psychological states such as depression are
associated with increased biomarkers of inflammation which are linked to CAD (Black,
2003; Dugue, Leppaen, Teppo, Fyhrquist & Grasbeck, 1993). Inflammatory cytokines
such as interleukin-6, tumor necrosis factor (TNF), and C-reactive protein are among the
biomarkers noted in the association between stress and inflammation. Many studies have
shown a mind-body connection, specifically with psychological states such as depression
and stress and their influence on bodily reactions such as their effects on the immune and
inflammatory systems (Dugue, Leppaen, Teppo, Fyhrquist & Grasbeck, 1993;
Hapauarachchi, Chalmers, Winefield & Blake-Mortimer, 2003; Ladwig, Marten-Mittag,
Lowel, Doring & Koenig, 2003; Lesperance, Frasure-Smith, Theroux & Irwin, 2004).
In 2003, the American Heart Association and the Centers for Disease Control and
Prevention published a joint scientific statement in Circulation, stating that from a
pathological viewpoint, all stages of atherosclerosis, which include initiation, growth, and
complication of atherosclerotic plaque, might now be considered to be an inflammatory
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issue (Person, et al., 2003). This redirects the idea that atherosclerotic plaque is primarily
due to excess LDL cholesterol level in the blood. A recent study found that C-reactive
protein (CRP) level is a better predictor of cardiovascular events than the LDL
cholesterol level (Ridker, 2002).
Many things, such as injury and pathogen invasion, can trigger the process of
inflammation resulting in CRP production (Dovi, Szpaderska & DiPietro, 2004; Sumi,
Satoh, Ishikawa & Sekizawa, 2004). However, studies show that psychological factors,
such as depression, stress and terror can also induce an inflammatory response
(Lesperance, Frasure-Smith, Theroux & Irwin, 2004; Hapauarachchi, Chalmers,
Winefield & Blake-Mortimer, 2003; Melamed, Shirom, Toker, Berliner & Shapira,
2004). In particular, stress is seen to activate the acute phase response, which is part of
the innate immune inflammatory response (Black, 2003). Based on this association,
psychological stress may be a focus area for intervention in the future for preventive
measures targeting heart disease risk and risk of future cardiac events.
Other than obesity, there are no specific physical findings that show a correlation
with the body and general CRP levels. However, many patient conditions and
characteristics, such as hyperglycemia, metabolic syndrome, chronic infection, weight
loss, medication and alcohol consumption, are associated with increased or decreased
levels of CRP using the high sensitivity CRP (hs-CRP) test (King, Mainous & Taylor,
2004). High sensitivity CRP testing (hs-CRP) is used in the detection of atherosclerosis
because atherosclerosis is now being considered an inflammatory disease (Ladwig,
Marten-Mittag, Lowel, Doling & Koenig, 2003; Ridker, Fifai, Rose, Buring & Cook,
2002; Ferranti & Rifai, 2002). The initiation of an inflammatory response can be
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detected by examining liver activity. Liver cells, also known as hepatocytes, are very
active in the production of acute-phase reactants, which are used as biomarkers for
inflammation. Acute phase reactants are a diverse group of proteins regularly seen
during acute and chronic systemic inflammation reactions. These proteins are part of the
host’s defense mechanism against tissue damage and infection. During acute, systemic
inflammatory diseases, hormonal mediators such as interleukin-6, tumor necrosis factor-a
(TNF- o;), glucocorticoids, and interferon-7 are produced in the liver (Feldman:
Sleisenger & Fordtran’s Gastrointestinal and Liver Disease, 2002). Interleukin-6 and
tumor necrosis factor-o; are major modulators of the inflammation biomarker C-reactive
protein (CRP). C-reactive protein is a pentamer consisting of five identical,
noncovalently linked, 23-kD subunit produced in the liver at increased levels during
inflammatory states (Ruddy, 2001). Elevations of inflammatory mediators may
contribute to the pathogenesis of atherosclerosis, because atherosclerosis is actually the
inflammation of the arterial wall (Dandona & Aljada, 2002).
When the body experiences a physical invasion or imbalance, inflammation is
triggered. For example, high levels of CRP are found in individuals with acute bacterial
infections, major trauma, systemic vasculitis and viral infections. It is now clear, due to
recent studies, that psychological issues may be added to the list of factors that influence
elevated hs-CRP levels (Ruddy, 2001). Ladwig, Marten-Mittag, Lowel, Doring and
Koenig (2003) studied the relationship of depressive mood to high sensitivity C-reactive
protein (hs-CRP) in 3,205 males, of which 726 (23%) were obese. Although no
association of hs-CRP and depression across all subjects was found there was a clear
association of elevated CRP levels and depression in obese males (F=4.9, p=.008). These
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results indicate that obesity and mental state may interact to elevate hs-CRP levels.
Although the Ladwig, et al study cannot determine causality, obesity may have a
synergistic relationship with psychological factors that may ultimately lead to disease
states or damage to the body.
The problems of obesity and CAD can have devastating impact on general health
and quality of life (Neilson & Schneider, 2005). Intervention strategies such as lowering
weight and total and LDL cholesterol levels, are used to combat these conditions. These
practices are important to reducing risk of cardiac events due to CAD; however, more
research is needed to uncover other variables, such as psychological factors, that can be
targeted to enhance prevention and treatment strategies for heart disease.
The concept that the mind can activate an inflammatory response is important
because of its implications for CAD. Research that examines the possible association of
obesity, psychological factors and inflammation may lead to the identification of new
intervention points for CAD prevention. The present study examined the idea that
psychological state is associated with inflammation among overweight and obese males,
as indicated by hs-CRP levels, which in turn is related to increased risk of CAD.
Therefore, the association of stress and hs-CRP levels in overweight and obese
individuals may increase the risk of CAD.
Therefore, the present study investigated a relationship, as depicted in Figure 1, of
how stress level might influence hs-CRP levels in the blood, thereby increasing
atherosclerotic risk in overweight or obese males. Ladwig, et al. (2003) suggested a














Figure 1. Proposed pathway of events related to stress, hs-CRP and atherosclerosis
adapted from Ladwig, et al (2003). (Elevated stress level increases level of hs-CRP
resulting in atherosclerosis.)
B. Purpose of the Study
Ladwig, et ah, studied the relationship of depressive mood to CRP in obese men.
Psychological states other than depressive mood may be associated with increased CRP
levels in obese and overweight individuals. Using the Ladwig, et al. study as a template,
the present study examined stress instead of depressive mood as the psychological state
that potentially triggers elevated hs-CRP levels. The purpose of the current study was to
investigate the relationship of perceived stress to hs-CRP levels in overweight and obese
males.
C. Research Questions
(1) Is there a positive association between hs-CRP levels and psychological stress
levels in overweight and obese males?
(2) If there is a positive association between hs-CRP levels and stress, does it apply
to both obese and overweight males?
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(3) Is there a positive association between hs-CRP levels and stress levels in
overweight and obese males using body mass index versus bioelectrical
impedance as a measure of overweight and obesity?
D. Significance to Preventive Care
Currently, preventive care practitioners and other health care professionals use
LDL cholesterol levels and other risk factors such as diet and exercise practices to screen
for cardiovascular risk. However, testing hs-CRP in clinical practice to determine
cardiovascular disease risk diagnosis is gaining acceptance (Ridker, Rifai, Rose, During
& Cook, 2002). The American Heart Association and the Centers for Disease Control
and Prevention (2003) have made an official statement of the importance of inflammation
markers when evaluating risk for cardiovascular disease. “.. .it is reasonable to measure
hs-CRP as an adjunct to the major risk factors to further assess absolute risk for coronary
disease primary prevention” (cf, Pearson, et al, 2003, p. 509). When considering
secondary prevention they state, “In patients with stable coronary disease or acute
coronary syndromes, hs-CRP measurement may be useful as an independent marker for
assessing likelihood of recurrent events, including death, myocardial infarction, or
restenosis after percutaneous coronary intervention” (cf, Pearson, et al, 2003, p. 509).
Therefore, hs-CRP levels are likely to be given more value in clinical practice in the
future.
Healthy People 2010, objective 12-1, emphasizes the need for a 20% reduction of
coronary heart disease deaths between 2000 and 2010. In addition, objective 20-9
emphasizes a 13% increase in worksite programs that prevent or reduce employee stress
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(Healthy People 2010; 1998). If the present study shows a positive association between
hs-CRP levels and stress levels among an already at-risk population of overweight and
obese males, further studies can be done to determine if stress reduction is a possible
strategy to lower cardiovascular events by way of hs-CRP reduction. If no relationship is
found, physiologically different mechanisms may be present that are unique to depression




The influence of psychological stress on the body, and its potential relationship to
atherosclerosis by way of inflammation in obese men, is a new concept. The relationship
between the mind and body is rapidly gaining more attention. The importance of the
body working as a whole dynamic system is seen by increased attention and research in
the field of psychoneuroimmunology (Dugue, Leppanen, Teppo, Fyhrquist & Grasbeck,
1993; Black, 2003; Padgett & Glaser, 2003). The proposed study attempted to link the
areas of stress, inflammation, and obesity with the goal of identifying new areas for
cardiovascular disease prevention. In order to understand the proposed link, each area
needs to be defined and explained. The chain of events discussed is how psychological
stress might influence inflammation (as detected by hs-CRP), in overweight and obese
males.
A. Psychological Stress and Body Pathways
Many studies have been done on the effect of psychological stress on the immune
system (Dugue, Leppanen, Teppo, Fyhrquist & Grasbeck, 1993; Black, 2003; Padgett &
Glaser, 2003). The term stress can be used in a very general and broad sense. However,
the cause of stressors can be broken down into external versus internal stressors.
External stressors, as perceived by the individual, defined as events such as divorce or
death of a loved one, is a type of cognitive sensory stimulus initially processed through
the peripheral and central nervous systems. Internal stressors are considered non-
cognitive stressors, which include bacterial and viral infections processed by the immune
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system first and passed through to the neuroendocrine system (Blalock, 1984). Cognitive
stress, the focus of this investigation, has been associated with psychoneuroimmunology
(PNI) concepts, clinical research and application (Bauer-Wu, 2002). PNI is a field that
studies the multifaceted bi-directional interaction between the immune system and the
central nervous system (CNS). Central to this field is the influence of psychosocial
factors on physical health (Cohen & Powderly, 2004).
There is a cascade of events that occurs in the body upon exposure to stressful
events. This cascade begins in the CNS. The impact of the CNS on the immune system
is primarily mediated by changes in the activity of the hypothalamic-pituitary-adrenal
(HPA) and sympathetic adrenal-medullary (SAM) axes. As part of the stress response,
these systems are activated causing an upregulation in plasma levels of glucocorticoids
and catecholamines. Glucocorticoids and catecholamines are classes of
immunomodulatory hormones capable of binding to cytoplasmic receptors on leukocytes
that alter their function and distribution (Cohen & Powderly, 2004). This summarizes the
link between the psychological stress beginning in the CNS and ending in a biochemical
effect on the immune system.
Another link that exists occurs between the immune system and other biological
systems dealing with cytokines. Immune cells produce cytokines which maintain
homeostasis by acting as modulators of the immune system. These cytokines have been
shown to communicate with other biological systems such as the HPA. If imbalances or
alterations occur in the function of these immunomodulators, illness usually results
(Wong, 2002). This demonstrates the bi-directional effect of the immune system
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affecting the HPA. Although not the direct focus of this study, this provides background
on the influence of the immune system and other systems and mechanisms in the body.
There is an established bi-directional relationship between the stress (mind) and
the immune system (body) (Wong, 2002; Cohen & Powderly, 2004; Bauer-Wu, 2002).
This link is important to the proposed study because it investigates the possible
association between psychological stress and the immunological response of
inflammation in individuals (overweight and obese) already at risk of inflammation.
B. High Sensitivity C-Reactive Protein
Hs-CRP is a marker of inflammation, primarily produced in hepatocytes and
regulated by interleukin 6 (IL-6), interleukin 1 (IL-1), tumor necrosis factor alpha (TNF-
alpha) and other cytokines (Rerranti & Rifai, 2002). Recent studies have shown that
elevated CRP is associated with increased risk of atherosclerosis (Ridker, Rifai, Rose,
Buring, & Cook, 2002). This classical acute-phase protein is a very sensitive systemic
marker of disease with broad clinical uses for monitoring disease status and providing
differential diagnosis of disease state.
High sensitivity C-reactive protein is found circulating in the blood of healthy
individuals; however, upon situations such as bacterial invasion or injury an acute phase
response results which increases hs-CRP levels drastically. Serum concentrations begin
rising approximately six hours, peaking approximately 48 hours after only a single
stimulus. In the majority of diseases, circulating values of hs-CRP are more accurate
when determining current inflammation than other methods such as plasma viscosity and
erythrocyte sedimentation rate. This is explained by the even half-life of hs-CRP. Hs-
CRP’s half-life stays constant around 19 hours under all conditions; therefore, the only
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determinant of the plasma concentration is synthesis rate which therefore reflects
intensity of the pathological processes stimulating CRP production (Hirschfield & Pepys,
2003). Other than obesity there are no specific physical conditions that correlate with
general CRP levels. However, hyperglycemia, metabolic syndrome, chronic infection,
weight loss, medication and alcohol consumption, are conditions associated with
fluctuations of CRP using the high sensitivity CRP (hs-CRP) test (King, Mainous &
Taylor, 2004).
CRP values are a very helpful non-specific biochemical marker of inflammation
(Hirschfield & Pepys, 2003). They are not impaired by disease states other than liver
failure. Very few drugs reduce CRP values unless they also affect the underlying acute-
phase stimulus. This is helpful in the clinical setting because most patients would qualify
and benefit from the hs-CRP test with the understanding that their results will be skewed
by illness or by being placed on certain medications.
In a review of the literature, Rosenson and Koenig (2003) discuss studies that
support the concept that system measures of CRP actually reflect the number of
vulnerable atherosclerotic plaques. In addition, they review studies that show elevated
CRP (greater or equal to 3 mg/L) levels predict an increased rate of recurrent ischemic
episodes, progression to acute myocardial infarction and revascularization procedures
when compared to those with lower CRP levels. The American Heart Association and
the Centers for Disease Control and Prevention developed a scientific statement on
markers of intervention and cardiovascular disease stating that individuals with an LDL
cholesterol level below the standard for initiating drug therapy and a Framingham ATP
III 10-year score (10%-20%) is an individual that warrants hs-CRP testing (Pearson et al,
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2003). The rationale for this recommendation is that people fitting into an intermediate
risk category with an elevated hs-CRP level would provide a reason for beginning lipid­
lowering therapy (Davidson, 2004). Pai, et al. (2004) showed that elevated levels of
certain inflammatory markers, in particular hs-CRP, indicate an increased risk of
coronary heart disease. They studied 504 subjects testing for plasma levels of sTNF-Rl,
sTNF-R2, interleukin-6, and hs-CRP. Among subjects who provided a blood sample and
were free of heart disease at baseline, 265 men and 29 women had a nonfatal heart attack
or fatal coronary heart disease during six and eight years of follow-up, respectively.
Plasma lipid levels had a stronger association with increased risk of CHD than were the
other inflammatory markers tested; the level of hs-CRP remained a significant
contributor to the prediction of coronary heart disease after controlling for lipid and non­
lipid factors.
Further investigation is needed on the specific role that inflammation plays in
CAD as determined by hs-CRP. This topic warrants further attention and serious
consideration because of its possible impact on diagnosis and prevention of CAD in the
clinical setting. However, based on the information that currently exists, hs-CRP testing
is recommended upon the discretion of the physician, especially in individuals with stable
coronary disease (Pearson et al, 2003). When using the available inflammatory measures,
hs-CRP holds the most promise as a possible screening tool for cardiovascular disease.
The American Heart Association and Centers for Disease Control and Prevention (2003)
issued a statement that hs-CRP testing may be most useful as a means to augment risk
assessment in patients who have already been identified at some risk due to other factors
such as hyperlipidemia. However, it is clear that further clinical trials are needed to
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establish whether elevated hs-CRP itself needs to be screened for and treated when
present in isolation (King, Mainous & Taylor, 2004).
C. Stress, the Immune System and Inflammation
The release of catecholamines, glucocorticoids and endogenous opiates are
significant in the field of PNI because immune and neuroendocrine cells have receptors
for these stress hormones (Bauer-Wu, 2002). In a review of the literature, Kiecolt-
Glaser, McGuire, Robles and Glaser (2002) concluded there is sufficient data to deduce
immune modulation by psychosocial stressors can lead to actual health changes.
The implications of the association between psychological stress and the immune
system span a wide variety of outcomes. For example, immune dysregulation induced by
stress can lead to conditions related to aging, osteoporosis, arthritis, type 2 diabetes, some
cancers and cardiovascular disease (Kiecolt-Glaser, McGuire, Robles & Glaser, 2002).
The literature published on stress has shown many of the same results. The following are
examples of such research. Schleifer, Keller, Camerino, Thornton and Stein (1983)
studied 15 spouses of women who had advanced breast cancer. They found that when the
breast cancer victim died, suppressed immunity followed in the surviving spouse. They
specifically tested lymphocyte stimulation responses to phytohemagglutinin,
concanavalin A, and pokeweed mitogen. Irwin, Daniels, Smith, Bloom, and Weiner
(1987) studied women whose spouses had died and also found suppressed immunity in
the surviving spouse, in the form of decreased natural killer cell activity. A dramatic life
event that induces psychological stress is experiencing the death of a loved one. In these
studies, the surviving spouse experienced suppressed immunity as a result of stress. This
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demonstrates that life events not only affect an individual’s psychological state but can
also open the body to pathogens and other physiological reactions.
The psychological stress experienced by many college students has also shown to
produce an immune response. Paik, Toh, Lee, Kim and Lee (2000) studied 42 college
students and examined their blood the day before an examination and again at four weeks
later. They found an increase, prior to the exam, in Th2 cell-mediated humoral
immunity and macrophage activities and a possible decrease in Thl cell-mediated
cellular immunity indicating an activation of the immune system. Specifically, stress
caused by the upcoming academic examination increased IL-1 beta, IL-6, and IL-10 and
decreased IFN-g production.
Exposure to trauma can result in immune dysregulation in the realm of post-
traumatic stress disorder (PTSD). PTSD is associated with inflammatory conditions such
as cardiovascular disease, rheumatoid arthritis and inflammatory bowel disorders (Wong,
2002). The studies described above establish an association between psychological stress
and the immune system even when different sources of stress are involved.
Psychological stress has also been linked to the susceptibility of infection. Cohen,
Tyrrell and Smith (1991) studied psychological stress and the common cold. Subjects
were asked to complete questionnaires assessing degrees of psychological stress and 394
healthy subjects were given nasal drops containing one of five respiratory viruses.
Twenty-six subjects were used as controls and were given saline nasal drops. The
subjects were then quarantined and watched for the development of infection and
symptoms. Clinical colds were defined as clinical symptoms in the presence of an
infection confirmed by the isolation the virus or presence of increased levels of a virus-
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specific antibody titer. The authors concluded that psychological stress was associated,
in a dose response manner, with an increased risk of acute infectious respiratory illness.
They suggest that the risk was attributable to increased rates of infection rather than to an
increased frequency of symptoms after infection.
The association between cognitive stress and the immune system is important for
the present study because it links the two areas together. Specifically, the study
examined the possible association of psychological stress and the immunological reaction
of inflammation as assessed by hs-CRP, in overweight and obese men, who are already at
risk for increased hs-CRP levels.
The association between psychological stress and hs-CRP as a marker of
inflammation has not been as thoroughly investigated as stress and other forms of
immunological response noted above. However, in 2001, Steptoe, Willemsen, Owen,
Flower and Mohamed-Ali investigated the influence of acute mental stress on the
cardiovascular responses and concentrations of inflammatory cytokines. Their results
showed a 56% increase in interleukin 6, a major modulator of hs-CRP, two hours after
stressful behavioral tasks (color-word interference and mirror tracing). This suggested
that inflammatory cytokines respond to acute mental stress in humans.
Hapauarachchi, Chalmers, Winefield and Blake-Mortimer (2003) measured
various markers of psychological stress and correlated them with biological markers such
as hs-CRP, homocysteine, salivary immunoglobulin A and oxidative stress in 76 healthy
individuals of various weights. They assessed stress and other psychological variables
using the General Health Questionnaire (GHQ-12), Copenhagen Burnout Inventory,
Perceived Stress Scale, Anger Expression Scale, Nowack’s Coping Scale, Occupational
16
Role Questionnaire, Occupational Strain Questionnaire, Nowack’s Social Support Scale
and the Warr, Cook, and Wall Scale for job satisfaction. Among their results they
showed that psychological stress is associated with pro-inflammatory states as evidenced
by increased hs-CRP concentrations. Specifically they found mean differences between
the normal (mean=1.09) and severely (mean=3.36) stressed for hs-CRP levels (p< .05).
Dugue, Leppaen, Teppo Fyhrquist and Grasbeck (1993) studied whether
psychological stress influenced immunobiological functions. Two kinds of stress were
studied: the Stroop color conflict test and the thrill of a first time parachute jump. The
level of stress indicators cortisol or anti-diuretic hormone rose significantly in both test
situations. The concentrations of the cytokines studied did not change. However, the
parachute test showed a significant positive correlation between changes in cortisol and
hs-CRP. Their results suggest that there is a positive interaction between the endocrine
and the immune system in the response to an acute psychological stressful experience.
Melamed, Shirom, Toker, Berliner and Shapira (2004) studied the association of
fear of terror with low-grade inflammation among apparently healthy employed adults.
They studied 1,153 subjects, of various body weights, assessing terror by measuring the
extent to which respondents have deep concerns for personal safety, elevated tension in
crowded places, and fear of terror strikes causing harm to one’s self or one’s family.
They concluded that chronic fear of terror is associated with elevated hs-CRP levels
(adjusted OR = 1.7, 95% CI=1.2-2.4) suggesting the presence of low-grade inflammation
and a potential risk of cardiovascular disease. However, this association was found only
in women, not men, suggesting that there may be different inflammatory processes in
action between the genders.
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Hossain, Latif, and Udin (2005) studied Bangladeshi people to see if hs-CRP is a
sensitive marker of an individual experiencing a stressful state in both the mind and body.
They studied 55 subjects, ages 18-55, over a one year period. They defined stressful
conditions as those who had infection, psychiatric disorders and those who were post
surgery. Based on different kinds of stress they divided their experimental group into
four subgroups: infection, psychiatric, pre and post surgery. They found a statistically
significant rise of hs-CRP levels seen in the infection, psychiatric disorder and post
surgery stage groups. They concluded that stressful conditions resulted in an increased
synthesis of hs-CRP by liver cells due to hypothalamopituitaryadrenal (HP A) axis
hyperactivity and immune mediated inflammation.
C-reactive protein is currently being investigated in order to establish the hs-CRP
test as a viable and accurate test for heart disease. Biasucci (2004), reporting on a
Centers for Disease Control and Prevention and American Heart Association workshop
on markers of inflammation and cardiovascular disease, states that hs-CRP has
consistently been found to be independent from other risk factors for cardiovascular
disease. Hs-CRP has also been shown to have an incremental value beyond the common
risk factors and biochemical markers of risk such as interleukin-6, interleukin-IRA and
troponin.
The above studies show that a relationship exists between psychological stress,
especially acute stressors, and the immune system, specifically inflammation. Some
studies have specifically used hs-CRP testing to detect the presence of an inflammatory
immunological response to stress.
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D. Depression, Obesity and High Sensitivity CRP
Barth, Schumacher and Hermann-Lingen (2004) conducted a meta-analysis on
depression as a risk factor for mortality in patients with coronary heart disease (CHD).
They searched English and German databases from 1980 to 2003 for prospective cohort
studies and identified 62 publications. They found that depressive symptoms and clinical
depression increases mortality in CHD patients. Miller, Freedland, Duntley and Carney
(2005) examined depressive symptoms associated with markers of infection and
inflammation related to pathogenesis of coronary artery disease. After studying 65
patients recovering from an acute coronary syndrome, they found that patients who had
more severe depressive symptoms exhibited higher levels of hs-CRP.
Suarez (2004) studied hs-CRP’s association with psychological risk factors of
cardiovascular disease in healthy adults. He studied 127 healthy, nonsmoking men and
women and found that greater anger and severity of depressive symptoms, separately and
in combination with hostility, were significantly associated with increased CRP levels.
Furthermore, these associations were independent of potential confounding factors.
Ladwig, et al. (2003) conducted a population-based study of 3,204 men aged 45-
74. They investigated the influence of depressive mood on the association of hs-CRP and
obesity in healthy men. Obesity, defined as a body mass index greater than 30, was found
in 726 individuals (23% of sample). A non-fasting venous blood sample was taken from
all participants in a supine resting position and hs-CRP levels were measured using a
high-sensitive immuno-radiometric assay (hs-CRP with a range of 0.05-10.0 mg/L). In
addition, depressive symptomatology was assessed using a subscale from the von Zerssen
affective symptom check list. The sample was stratified into three levels of depressive
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mood which revealed a significant association (p=.008) between increased hs-CRP in the
obese sample with highest level of depression (n=147, hs-CRP adjusted mean=3.22)
when compared to moderate (hs-CRP adjusted means=2.44) and low (hs-CRP adjusted
mean=2.43) level depression groups.
The obesity and depression interaction was found to be significant (p= 021).
There was no association between depressive mood and concentrations of hs-CRP in the
non-obese group. Multivariate analysis confirmed this interaction after adjusting for
possible confounders such as smoking, high blood pressure and age.
The present study used the Ladwig, et al. research as a template to investigate a
possible association between psychological stress, obesity and increased hs-CRP
concentrations. This study attempted to examine stress as the psychological factor as the
potential trigger for elevated hs-CRP levels.
E. Inflammation and Atherosclerosis
Inflammatory processes can cause a variety of responses by the host; the
responses collectively are referred to as an acute phase response. This response is
associated with distinctive metabolic changes in liver protein synthesis. The resulting
changes are called acute, mainly because results can be seen within a short period of time
(Goldman, 2000). Stress can activate an acute phase response (APR), part of the innate
immune inflammatory response which gives evidence that the inflammatory response, is
contained within the stress response or that stress can induce an inflammatory response
(Black, 2003).
Interestingly, atherosclerosis is now considered an inflammatory disease. The
lesions characteristic of atherosclerosis represent a series of specific cellular and
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molecular responses that can accurately be described collectively as inflammatory
disease. These lesions can lead to ischemia of the heart, brain or extremities resulting in
infarction (Ross, 1999).
It is common for lesions to be present throughout a lifetime. The earliest lesions
are called fatty streaks. Fatty streaks are pure inflammatory lesions consisting of
monocyte-derived macrophages and T lymphocytes, key players in inflammation. In the
occasion of excessive and persistent chronic inflammatory processes in the artery, a
complicated lesion may result (Ross, 1999). Coronary artery inflammation is involved in
all stages of lesion or plaque formation. Lesions can rupture precipitating clotting in
patients with myocardial infarction, unstable angina, stenosis, total vessel blockage and
sudden death. Unstable lesions have thin, fibrous caps overlying a core rich in lipids
containing inflammatory cells that include proteins such as fibrinogen and hs-CRP, which
are important determinants of plaque rupture (Rosenson & Koenig, 2003).
Chronic inflammation can result in increased numbers of macrophages and
lymphocytes, which immigrate from the blood and have the potential of multiplying in
the lesion (Ross, 1999). Activation of these cells leads to the release of many substances
including cytokines which modulate the inflammatory marker hs-CRP. Hs-CRP is
present in trace concentrations in human plasma; however, when the body experiences
inflammatory states, hs-CRP levels rise. The concept that atherosclerosis is an
inflammatory disease has clinical significance in that it can be detected easily by the hs-
CRP test (Ridker, Fifai, Rose, Buring & Cook, 2002; Ferranti & Rifai, 2002; Ladwig,
Marten-Mittag, Lowel, Boring & Koenig, 2003). With atherosclerosis accepted as an
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inflammatory disease detected by using the hs-CRP test, the proposed study can
incorporate this test as a marker of atherosclerotic risk.
F. Obesity and C-Reactive Protein
Overweight and obesity prevalence continues to dramatically increase in the
United States. Currently, more than half of all U.S. adults are overweight or obese. In
general, people who become obese do so because of a combination of genetics and a
lifestyle which consists of low levels of physical activity and high levels of caloric
consumption (Sower, 2003). There have been several studies linking obesity and hs-
CRP. Aronson, et al. (2004) found that obesity was one of the major factors associated
with elevated hs-CRP in individuals with metabolic syndrome. Metabolic syndrome is a
cluster of disorders characterized by abdominal obesity, high blood pressure, high
triglyceride level, high fasting glucose level and low HDL cholesterol level. This
increased hs-CRP level indicates that obesity may also have an influence on the
inflammatory response given that hs-CRP is a biomarker of inflammation.
Weiss, et al. (2004) studied obesity and the metabolic syndrome in adolescents
and children. They found that hs-CRP levels rose with increasing obesity, suggesting
that biomarkers for cardiovascular disease are already present in this young age group.
Wamberg, Moreno, Mesana and Marcos (2004) studied 493 Spanish adolescents who
were 13 years old. Although they did not study if adolescent overweight and obesity
initiate the development of future disease, they did suggest that obesity states may induce
a chronic low-grade inflammatory state as evidenced by a rise in hs-CRP levels.
Although specific mechanisms have not been identified, this points to the importance of
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maintaining proper body weight in adolescence in the effort to avoid obesity-related
disease and chronic inflammation in adulthood.
Pannacciulli, et al. (2001) investigated whether hs-CRP concentrations are
influenced by insulin resistance, body composition and body fat distribution in 201
healthy women. They found that hs-CRP was positively correlated with age, body mass
index, waist, fasting glucose and insulin, insulin resistance, fat free and fat mass. This
study showed there is an independent relationship between central fat accumulation and
insulin resistance with hs-CRP plasma levels. Greenfield, et al. (2004) studied obesity as
an important determinant of baseline serum hs-CRP concentrations in monozygotic
twins, independent of genetic influences. They studied 194 healthy female twins and
found that hs-CRP was strongly related to total central abdominal obesity, blood pressure
and lipid levels, independent of genetic factors.
Khaodhiar, Ling, Blackburn and Bistrian (2004) examined the correlation of
inflammatory markers such as tumor necrosis factor-alpha (TNF), soluble TNF receptor
II (sTNF-RII) and, interleukin 6 (IL-6) with BMI in nonobese, obese and morbidly obese
individuals. Their study supported idea that obesity represents an inflammatory state.
They found that in morbidly obese individuals only, there was a correlation of IL-6 and
hs-CRP with BMI, particularly in males. This suggests that IL-6 may be secreted in an
endocrine manner in proportion to the expansion of fat mass, specifically in the
abdominal region. In addition, this increase corresponded with an increase in hepatic
production of hs-CRP. Lee and Prately (2005) also studied the evolving role of
inflammation on obesity. They state that it is now clear that the adipocyte is an active
participant in the generation of the inflammatory state experienced in obese individuals.
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Adipocytes secrete a variety of cytokines such as IL-6 which promotes inflammation.
The authors state that an improved understanding of the role of adipose tissue and the
characteristic activation of inflammatory pathways could suggest possible novel
treatments and prevention strategies, such as fat reduction methods, aimed at reducing
obesity-associated morbidities and mortality.
Vozarova, Weyer, Hanson, Tataranni, Bogardus and Pratley (2001) studied
circulating interleukin-6 (IL-6) in relation to adiposity, insulin action and insulin
secretion. Adiposity was measured by dual energy x-ray absorptiometry (DXA), a high
speed fan beam scanner which measures body composition. Results showed that IL-6, a
key modulator in hs-CRP production, was positively related to adiposity, suggesting that
hs-CRP production may be increased by way of IL-6 because of increased fat.
Furthermore, Laimer, et al. (2005) studied the effect of weight loss on nontraditional
cardiovascular risk markers such as hs-CRP, interleukin-6 (IL-6) and matrix
metalloproteinase-9 (MMP-9), in middle-aged morbidly obese women. They studied 45
morbidly obese women before gastric banding and one year post surgical treatment.
They concluded that weight loss is associated with a pronounced decrease in
nontraditional cardiovascular risk markers such as hs-CRP, indicating beneficial effects
of weight loss on cardiovascular risk.
The above studies show an association between adiposity and hs-CRP, indicating
obesity is related to the body’s inflammatory immune response. The present study




In conclusion, there is evidence that a relationship exists between acute stress and
inflammation. There is also an established relationship between inflammation and
elevated hs-CRP as well as inflammation, atherosclerosis and increased hs-CRP levels in
the obese. No published studies have examined psychological stress and hs-CRP levels in
overweight and obese males. If an association is observed it may lead to a further
investigation of psychological stress as an intervention area for the prevention of CAD,





This study was a correlational or cross sectional study that measured the degree
of linear relationship between two factors measured within defined groups (Morgan,
1996). The defined group was overweight and obese males and the two factors were
psychological stress and hs-CRP level.
B. Subjects
Subjects were healthy males aged 20-35 recruited from Loma Linda University
Adventist Health Sciences Center (LLUAHSC) entities. Subjects were recruited via
flyers. Flyers were placed in the Loma Linda University Medical Center, each of the
seven schools that make up Loma Linda University (LLU) as well as the Drayson
Center, Del Webb Library and Student Services. (See Appendix A.) Mass e-mails were
sent to all students in LLU School of Public Health and to all LLU medical residents.
In addition, after each subject was tested they were asked to refer anyone who fit the
criteria for participation in the study. Flyers were also carried to many departments in
LLUASHC and subjects were personally invited to participate. Thirty-two subjects
were recruited to LLU Center for Health Promotion (CHP) for testing. Paperwork was
resubmitted to the Institutional Review Board for approval of recruitment and testing at
other locations. Upon approval, testing was set up at LLU Drayson Center, the
university’s fitness facility. Twenty-nine subjects were recruited and tested on site at
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the Drayson Center and given a bottle of water as a token of appreciation for
participation.
C. Inclusion/Exclusion Criteria
Subjects were included in the study if they were male and had a body mass index
(BMI) of 25 or above, classifying them as overweight or obese. Age was limited to
those ages 20-35 in order to reduce the influence of age as a confounding factor.
Participants were excluded if they were smokers or had any injuries or viral or bacterial
infections within the past 30 days. These states increase hs-CRP levels because of their
inflammatory effect on the body. Participants were also excluded if they had taken any
form of anti-inflammatory medication within 48 hours of testing. Participants were
excluded if they had taken medications such as, but not limited to, aspirin, ibuprofen,
naproxen and prescription NSAIDS within 48 hours. The use of these medications
decreases hs-CRP levels because of their anti-inflammatory properties.
D. Instrumentation
The primary variables assessed are listed below.
1. Perceived Stress Scale
The Perceived Stress Scale (PSS) is a widely used psychological tool
which measures the perception of stress. The PSS was used to measure the degree to
which life’s situations are appraised as stressful. Each item was designed to assess how
individuals find their lives to be unpredictable, uncontrollable and overloaded. The scale
contains 10 questions using Likert-type response questions (Cohen, Tyrrell & Smith,
1993). “The PSS has adequate internal and test-retest reliability and is correlated in the
expected manner with a range of self-report and behavioral criteria (r=.65, p<.05)”
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(Cohen, Kmarack & Mermelstein, 1983, p. 392). (See Appendix B.)
2. Blood Pressure
Blood pressure was taken using a standard blood pressure cuff and scale.
Blood pressure was taken on the left arm in a relaxed sitting position.
3. Body Mass Index/Body Fat
Height and weight were assessed using a regular dual reading eye-level
physician scale in order to calculate body mass index (BMI). Body fat percentage was
assessed using an Omron HBF-306, a handheld body fat analyzer. This bioimpedance
machine provides results in seven seconds and calculated BMI upon entering an
individual’s height and weight. Bioimpedance is a noninvasive method used to evaluate
body composition. A small electric current is passed through the hands and results are
based on the principal that body fat conducts electricity different than body muscle.
4. High Sensitivity CRP Testing
After blood samples were collected from participants, hs-CRP testing was
performed at Loma Linda University Medical Center’s clinical laboratory using high
sensitivity CRP testing (hs-CRP) to determine CRP levels. This technology uses two
monoclonal antibodies specific to CRP and forms a unique two-site combination for the
development of a fast and sensitive CRP assay (Advanced ImmunoChemical Inc.)
E. Procedures
Participants were invited to the exercise laboratory in Evans Hall and the
Martinson and Fritz room in the Drayson Center located on the Loma Linda University
campus. Subjects were given a verbal and written explanation of the study as part of the
informed consent process. (See Appendix C.) This included an explanation of the
28
benefits and risks of participation along with an explanation of the study. The subjects
were also told they would receive a telephone call informing them about their hs-CRP
results approximately two weeks after testing. Subjects were informed that if their test
results showed elevated hs-CRP they should to contact their primary care physician or
student health services for further care and evaluation.
1. Informed Consent Document
After subjects had signed the informed consent document (ICD), their
height and weight were measured in order to calculate their body mass index (BMI).
Height (feet and inches) and weight (pounds) were measured without shoes and articles
in subjects pockets. Height and weight measurements were then entered into the Omron
HBF-360, a hand-held fat analyzer, and BMI and body fat percentage were calculated
and assessed at the same time. If participants had a BMI of 25 or over they were
included in the study. If they had a BMI of less than 25 they were excused.
2. Screening
Subjects were then asked to fill out a screening form (see Appendix C) in
order to assess if they met study criteria. If they did not meet the criteria they were
excused; if they met criteria, subjects were given the 10 item Perceived Stress Scale.
This stress scale took approximately five minutes to complete.
3. Blood Draw
Lastly, subjects had their blood drawn for the purpose of hs-CRP testing.
The hs-CRP test is not affected by food consumption or time of day; therefore, blood
draws occurred at any time. The blood draws were taken in a sitting position using
antecubital venipuncture by a licensed phlebotomist. The site depended on the individual
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and which vein was more visible for puncture. A tourniquet was placed around the upper
arm to restrict blood flow through the vein, then antiseptic was applied to the site. This
technique causes the veins below the tourniquet to distend and fill with blood allowing
blood to be collected in an air tight vial. The tourniquet was then removed and the
puncture site was covered to stop any bleeding after the sample was taken.
Possible risks that can occur when puncturing a vein included excessive bleeding,
bruising, hematoma and numerous punctures in order to find a vein. In addition, some
individuals may become lightheaded or faint if they are uncomfortable with the sight of
blood, pain or needles. Subjects were informed of these possible risks both orally and in
writing in the informed consent document (ICD) and were given the opportunity to
withdraw their participation at any time. To reduce the risk of bruising, subjects were
advised to keep pressure on the site for 10 minutes after the needle was withdrawn. A
cotton ball held tight with tape was used to help subjects keep pressure on the site.
, Thirty-two of the blood draws were completed in the Center for Health Promotion, a
medical clinic capable of handling fainting or any other emergencies that may occur
beyond which the primary investigator or the phlebotomist can handle. Twenty-nine of
the blood draws were performed at the Drayson Center which is less than half a mile
from Loma Linda University Medical Center, a trauma 3 facility. The facility is capable
of handling major medical emergencies.
The blood samples were taken within an hour to Loma Linda University Medical
Center’s clinical laboratory for analysis. The hs-CRP test employs a method called
nephelometry. This method uses specialized instruments to measure the movement of
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particles in solution or turbidity (http://health/quantitative-immunoglobulins-
nephep://health.allrefer.com/ lometry-info.html, 2004).
At the end of the session, subjects were given a form with their recorded height,
weight, BMI, body fat percentage and blood pressure. In addition, the form contained a
brief description of hs-CRP risk categories. (See Appendix E.) There are three hs-CRP
risk categories for developing cardiovascular disease: low risk (< 1.0 mg/L), average risk
(between 1.0 - 3.0 mg/L), or high risk (>3.0 mg/L) (Centers for Disease Control and
Prenvention & American Heart Association, 2003). The author verbally explained these
risk categories to subjects at the time of the blood draw as well as over the phone when
subjects were informed of their results. If hs-CRP values were elevated, subjects were
strongly encouraged to contact their primary care physician or student health services for
further evaluation and care.
F. Statistical Analysis
Descriptives such as frequencies, means, outliers and normal distribution were
determined for all study variables. Correlations of hs-CRP levels, stress, body fat
percentage and BMI values were done to evaluate if a linear relationship existed among
these variables. The sample size of 60 was based on a power analysis of 80% and the
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Psychological Stress and High Sensitivity C-Reactive Protein Levels in Overweight
and Obese Men
In one study, depression was positively associated with high sensitivity C-reactive protein
(hs-CRP) in 726 obese men (Ladwig, et al, 2003), but little is known about how chronic
psychological stress might be associated with the same inflammatory processes. This
study investigated the influence of perceived stress of daily life and whether it is
associated with hs-CRP in overweight and obese males. Sixty-one men participated in
this study which included the 10-item Perceived Stress Scale (PSS) and hs-CRP testing.
There was no association between perceived stress and hs-CRP levels (r=.06, p^.65).
Hs-CRP levels were significantly associated with body mass index (r=.43, p—.OOl) and
body fat percentage (r=.49, p=.0001).
Over the past few years, high sensitivity C-reactive protein (hs-CRP) has received
much attention for its role in atherosclerosis (Pearson, Mensah, Alexander, Anderson,
Cannon, Criqui, Fadl, Fortmann, Hong, Myers, Rifiai, Smith, Tubert, Tracy & Vinicor,
2003; Rosenson & Koenig, 2003; Plutzky, 2001). This association was validated on
January 28, 2003, when the American Heart Association and the Centers for Disease
Control and Prevention published a joint scientific statement in Circulation, stating that
from a pathological viewpoint, all stages of atherosclerosis, including initiation, growth,
and complication of atherosclerotic plaque, might now be considered to be an
inflammatory issue (Pearson, et al., 2003). Subsequently, there are now many studies
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investigating the magnitude of the role hs-CRP plays in atherosclerosis and the accuracy
with which hs-CRP levels can predict future cardiac events (Arenillas, Alvarez-Sabin,
Molina, Chacon, Montaner, Rovira, Ibarra, & Quinanna, 2003; Folsom, Pankow, Tracy,
Arnett, Peacoch, Hong, Djousse & Eckfeldt, 2001).
The association between hs-CRP and atherosclerosis has spawned research into
factors that may amplify this association. Psychological variables such as depression,
hostility and fear have emerged as possible factors that lead to increased hs-CRP levels
(Melamed, Shirom, Toker,Berliner & Shapira, 2004; Miller, Feedland, Duntley &
Carney, 2005; Barth, Schumacher & Herrmann-Ligen, 2004). Suarez (2004) showed that
greater anger and severity of depressive symptoms, separately and in combination with
hostility, were significantly associated with elevations in hs-CRP. Melamed, et al.
(2004) showed elevated hs-CRP levels in women who experienced chronic fear of terror,
suggesting the presence of low-grade inflammation and a potential risk of cardiovascular
disease. Depression has also been shown to elevate hs-CRP levels (Miller, et al., 2005).
This mounting evidence shows that psychological factors may indeed have an
inflammatory effect.
Biological factors such as obesity also play a clear role in hs-CRP levels.
Adipocytes or fat cells are active participants in the generation of the inflammatory state
of obesity (Lee & Pratley, 2005). In addition, obesity using the measurement of body
mass index (BMI) is positively related to hs-CRP (Khaodhiar, Ling, Blackburn &
Bistrian, 2004; Laimer, 2005).
One study found that acute stressful conditions, defined as subjects experiencing
infection and psychiatric disorder in a post surgery stage, showed increased synthesis of
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CRP by liver cells due to hypothalamopituitaradrenal (HPA) axis hyperactivity and
immune mediated inflammation (Hossain, Latif & Uddin, 2005). This indicates a linkage
between the mind and body regarding acute stress states and increases in inflammation as
indicated by hs-CRP levels.
Ladwig, et al. (2003) studied the effect of depression on hs-CRP levels. They
found that hs-CRP concentrations were higher among males with depressive mood, but
only for those in the obese category. The authors used a subscalse from the von Zerssen
Affective Check List to assess depressive symptomology. The obese sample (n=726)
was stratified into three levels of depressive mood which revealed a significant
association (p=.008) between increased hs-CRP in those with the highest tertile of
depression (hs-CRP adjusted mean=3.22) compared to moderate (hs-CRP adjusted
means=2.44) and low (hs-CRP adjusted mean=2.43) level depression groups. According
to the CDC and American Heart Association (2003), statement hs-CRP risk categores are
as follows: <1.0=low risk, 1.0-3.0=average risk and >3.0 is high risk. Ladwig, et al.
state that psychological factors such as depression, and biological factors such as obesity,
when present together, can influence inflammatory processes associated with
atherosclerosis. The question then arises that if depression, a serious clinical mental
state, produces inflammatory processes in obese males, whether chronic psychological
stress might also produce an inflammatory response in a similar population.
No research has been published on whether hs-CRP levels increase due to chronic
stresses of daily life as perceived by the individual. The present study investigates the




Subjects were overweight or obese but otherwise healthy males aged 20-35. They
were recruited by word-of-mouth, flyers and personal invitation at a private health
science campus in Southern California. Subjects were included in the study if they were
male and had a body mass index (BMI) of 25 or above, classifying them as overweight or
obese. The sample was limited to those ages 20-35 in order to eliminate age as a
confounding factor. Participants were excluded if they were smokers or had any injuries
or viral/bacterial infections within the past 30 days. These states elevate hs-CRP levels
due to increased inflammation (Dovi, Szpaderska & DiPietro, 2004; Sumi, Satoh,
Ishikawa & Sekizawa, 2004). Participants were excluded if they had taken any form of
anti-inflammatory medication within 48 hours of testing, such as aspirin, ibuprofen,
naproxen and prescription NS AIDS. Main study variables included hs-CRP level,
psychological stress, body mass index (BMI), body fat percentage and blood pressure.
Exercise, perceived health status, religious attendance and sleep were also measured.
Procedures
Subjects were given a verbal and written explanation of the study as part of an
informed consent process. After subjects had signed the informed consent document,
their height and weight were measured in order to calculate their body mass index (BMI).
Height (feet and inches) and weight (pounds) were measured without shoes and articles
in subjects’ pockets. Height and weight measurements were then entered into the Omron
HBF-360, a hand-held fat analyzer, and BMI and body fat percentage were calculated
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and assessed at the same time. If participants had a BMI of 25 or over they were
included in the study. If they had a BMI of less than 25 they were excused.
Subjects were then asked to fill out a screening form in order to assess if they met
the rest of the study criteria. If they did not meet criteria they were excused; if they met
criteria subjects were given a 10 item Perceived Stress Scale (PSS). Lastly, subjects had
their blood drawn for the purpose of hs-CRP testing. The hs-CRP test is not affected by
food consumption or time of day; therefore, blood draws occurred at any time. Blood
draws were taken in a sitting position using antecubital venipuncture by a licensed
phlebotomist. These procedures were approved by the Institutional Review Board of
Loma Linda University.
Psychosocial Measures
Psychological stress was assessed by the Perceived Stress Scale (PSS), a widely
used psychological tool which measures the perception of stress. The PSS was used to
measure the degree to which life’s situations are appraised as stressful. Each item is
designed to assess how individuals find their lives to be unpredictable, uncontrollable and
overloaded. The scale contains 10 items using Likert-type response format (Cohen,
Tyrrell & Smith, 1993). “The PSS has adequate internal and test-retest reliability and is
correlated in the expected manner with a range of self-report and behavioral criteria
(r=.65, p<.05)” (Cohen, Kmarack & Mermelstein, 1983, p. 392).
Inflammatory Risk Marker
Hs-CRP testing was performed at Loma Linda University Medical Center’s
clinical laboratory using hs-CRP to determine blood levels. This technology uses two
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monoclonal antibodies specific to CRP and forms a unique two-site combination for the
development of a fast and sensitive CRP assay (Advanced ImmunoChemical, Inc.)
RESULTS
Descriptive Statistics
Sixty-one subjects were tested in total with a mean age of 26.9 (SD=4.2). The
mean PSS score was 14.08 (SD = 6.7), with a range of 1 to 33, with 40 being the highest
score possible. (See Table 1) Using body mass index categories of 25-29.9 as overweight
and 30 or above as obese, 28 (45.9%) were classified as overweight and 33 (54.1%) were
classified as obese. However, using body fat percentage categories, 33 (54%) were
classified as overweight (17%-25% body fat) and 28 (45.3%) were obese (>25% body
fat), with the result that nine subjects were classified differently depending on whether
BMI or body fat percentage was used. BMI values ranged from 25.5 to 48.2 with a mean
of 32.0 (SD=5.4). Body fat percentage values ranged from 12.7% to 38.2% with a mean
of 24.3 (SD=6.8). High sensitivity CRP levels ranged from .30 to 5.54, with 11 subjects
(18.3%) being in the high risk category (3 or above). (See Table 1) Comparisons on
study variables between overweight and obese categories, as determined by body fat
percentage, are shown in Table 1. After the Bonferonni adjustment for multiple
comparisons, four out of the six associations were no longer significant (p=.005).
Descriptive statistics for study variables between overweight and obese groups
showed PSS scores were higher in obese (mean=T2.8) compared to overweight
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^Groups based on body fat % where 17%-25% was overweight and >25% were 
classified as obese. **P-values reach Bonferroni-adjusted criterion of .005.
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(mean=15.2) men, but this difference was not significant. In the overweight group,
48.5% reported they were in fair or good health as compared to 85.7% of the obese group
(p=.02). Those in the obese group were older, and had higher systolic and diastolic blood
pressure, hs-CRP levels and BMIs. After the Bonferoni adjustment (p=.005) only BMI
and hs-CRP levels remained significantly different between overweight and obese
groups, which is consistent with other studies.
Perceived stress scores showed no significant association with hs-CRP levels
(r=.060, p=.647). (See Table 2) There was also no significant association between PSS
and hs-CRP when broken down into overweight (r^ - .01, p=.96) and obese (r=.04,
p^.QS) categories. Spearman Rho correlations were used because the distribution of hs-
CRP levels were not normal and because several of the other study variables such as
health status were on an ordinal scale. Hs-CRP levels were then transformed using
square root and log 10 calculations, which yielded a more normal distribution. However,
no association between hs-CRP values and PSS (using Pearson correlation) was found
even after the transformation. Body mass index was significantly associated with body
fat percentage (r=.90), systolic blood pressure (r=.37), hs-CRP (r=.43), and perceived
stress score (r=27). Body fat percentage was significantly associated with diastolic blood
pressure (r=.39) and hs-CRP (r=.49). Health status was negatively correlated with body
mass index (r=-.38) and body fat (r=-.36).
There were no significant associations for hours of sleep and BMI, body fat
percentage, hs-CRP levels and education level, religious service attendance and hours of
sleep.
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* After Bonferroni adjustment, p-value was . 005.
DISCUSSION
Similar to past research, both BMI and body fat percentage were significantly
positively associated with hs-CRP level, and CRP showed a slightly stronger associated
with body fat percentage (r=.592) than BMI (r=.546). This may indicate that the
measurement of body fat is a better predictor of increased levels of hs-CRP than the
measurement of height and weight alone. Interestingly, BMI showed borderline
significance and association to PSS (r=.233), whereas body fat percentage (r=.149) did
not. BMI and body fat percentage were also significantly associated with both systolic
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and diastolic blood pressures, as found in other research. However, both blood pressures
showed a stronger association with body fat percentage than BMI.
As expected, body mass index and body fat percentage were highly associated.
However, it is important to note that nine out of 61 subjects (14.7%) were classified
depending on composition measurements used. When using BMI, seven subjects were
classified as overweight whereas using body fat they were considered obese and two
were classified as obese but as overweight using body fat. Therefore, use of body mass
index should not to replace body fat testing when establishing overweight or obese
classification. Body mass index measures only height and weight; therefore, individuals
who have high muscle content leading to increased weight would be classified as obese
according to BMI measurements (Peterson, 2002).
This study did not show a linear association between chronic stresses of daily life
and hs-CRP levels (r= .06), even after transforming the non-normally distributed hs-CRP
values. If a relationship exists, it is likely a small effect size, which would only be
detected with more subjects and perhaps a more sensitive assessment of stress. The lack
of association in this study compared to other studies on stress and hs-CRP may be due to
the lower sample size, few subjects with hs-CRP values above 3, younger age and the
type of psychological state being tested in this study. For example, Ladwig et al. (2003)
showed there was an association between depressive mood among 726 obese subjects
men ages 45-74, whereas the current study investigated chronic stress of daily life among
61 overweight and obese men ages 20-35. The differences concerning age criteria and
psychological states of depression versus chronic stresses of daily life may account for
the differences between results of the present study versus the Ladwig et al. study.
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This study also found a negative association between body fat percentage and
perceived health status (r= -.361). Health status was not correlated with hs-CRP, when
controlling for body fat percentage r=-.08 (p=54), but body fat percentage and health
status were correlated (r=. 30, p=.02), when controlling for hs-CRP. This indicates the
strength of the association of health status is with body fat percentage and not hs-CRP.
Some studies have investigated the correlation between the presence of acute
psychological stressors and hs-CRP levels (Dugue, Leppaen, Teppo, Fyhrquist &
Grasbeck, 1993; Melamed, Shirom, Toker, Berliner & Shapira, 2004). Positive
associations were found, but the psychological states examined were fear of terror and the
thrill of a first time parachute jump, rather than of chronic stresses of daily life. These
acute states are likely different than the chronic stresses of daily life tested in this study
and may influence the inflammatory response in different ways.
Possible explanations for this difference may be due to variations in coping styles
of each individual. The way a person perceives and manages stress may have an impact
on how the body responds to various stressors. Individuals with positive ways of coping
are associated with low pro-oxidant states as indicated by lower CRP levels
(Hapuarachchi, Chalmers, Winefield & Blake-Mortimer, 2003). Another possible
explanation could be that the severity of the stressor may impact the body differently.
The intensity of the stressor may influence the amount of inflammation that occurs, but
this is yet to be examine directly.
Exercise status may also have played a role in the results of this study. Twenty-
nine (47.5%) subjects were recruited from the Drayson Center, a university gymnasium
and health facility. Forty-five (74%) subjects reported that they participated in vigorous
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exercise two or more days a week. These subjects were involved in exercise to a greater
extent than the general population, which could have influenced their response to stress,
how they coped with stress, or the inflammatory processes in the body. Although a good
distribution of stress values was found, it may suggest that these individuals have more
leisure time that would deem them less stressed or these individuals may have an
effective way to cope with stress. Exercise may counteract the negative effects of stress
on hs-CRP levels, if such effects exist.
The finding that chronic psychological stresses of daily life are not associated
with hs-CRP levels in overweight and obese males points to a need of further
investigations into the link between acute stress and depressive mood and how they differ
from stresses of daily life, types of stressors or coping mechanisms in relation to hs-CRP
levels. Depressive mood, acute stress and obesity states may have possible positive,
negative or even synergistic relationships with hs-CRP that are yet to be discovered. The
specific mechanisms and dose response of this mind-body connection are still largely
unknown.
This study confirmed a strong positive association of both BMI and body fat
percentage with hs-CRP but showed no relationship of chronic stress of daily life on hs-
CRP levels in overweight or obese males.
Strengths and Limitations
This study was based on sound measurements. The methodology included
validated and reliable measures of psychological stress, body mass index, body fat
percentage and hs-CRP. In addition, blood testing was completed within two hours of
each blood draw, which reduced possible errors caused by standing blood.
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The possibility of low power (sample size) did not allow for the detection of small
effect sizes or associations, if they exist, between the Perceived Stress Scale and hs-CRP;
however, small effect sizes may not be clinically significant. Clearly strong associations
of BMI, body fat and hs-CRP were detected in this sample and those associations are
clinically important. In addition, the use of a cross-sectional design does not allow for a
cause and effect relationship to be determined, if an association exists.
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Past studies show associations between acute stress situations and hs-CRP levels
in the blood (Dugue, Leppaen, Teppo, Fyhrquist & Grasbeck, 1993; Melamed, Shirom,
Toker, Berliner & Shapira, 2004). One study also found a positive relationship between
depressive mood and hs-CRP levels in obese men (Ladwig et al., 2003). These studies
contribute to the theory that the mind can have an influence on the body thereby causing
disease states. The present study was conducted to add to the growing amount of
research that furthers the understanding of this mind-body relationship.
This study found no linear association between chronic stresses of daily life as
measured by the Perceived Stress Scale (PSS) and high sensitivity C-reactive protein in
this sample of overweight or obese males. Spearman rho correlations were determined
because of the non-normal distribution of hs-CRP values which where highly positively
skewed. After log 10 and square root transformations which normalized the hs-CRP
distribution values, there was still no association between PSS score and hs-CRP.
The studies that have shown a correlation between stress and hs-CRP have
primarily measured acute psychological stress situations such as the thrill of a first time
parachute jump (Dugue, Leppaen, Teppo, Fyhrquist & Grasbeck, 1993) and fear of terror
of harm to themselves or their families due to terrorist strikes (Melamed, Shirom, Toker,
Berliner & Shapira, 2004). This dissertation study measured chronic stress, which may
have different mechanisms at work in its influence on inflammation as compared to
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chronic stress. Acute stressors are situations where stress occurs severely during a short
period of time as compared to chronic stress, which can be less severe but occurs over a
long period of time creating different reactions in the body.
Differences between acute and chronic stressors need to be further investigated to
uncover the variations in inflammatory responses. Differences such as intensity and
duration of stressors may be important factors that cause these differences. Differences
in inflammatory responses may also be caused by variations in coping styles (Marcenaro,
Prete, et al., 1999). The way one perceives stress and manages stress may possibly
change the way one’s body reacts to psychological factors.
Exercise status may have also played a role in the results of this study. Twenty-
nine (47.5%) subjects were recruited from the Drayson Center, which is a gymnasium
and health facility. Forty-five (73.7%) of subject reported exercising two times a week or
more, which could influence their stress level or CRP production. King, Baumann,
O’Sullivan, Wilcox and Castro (2002) conducted a 12-month randomized controlled trial
in 100 women aged 49 to 82. The objective of their study was to determine the health
and quality of life effects of moderate-intensity exercise among older women family
caregivers. They concluded that there are benefits from initiating a regular moderate-
intensity exercise program in terms of reductions in stress-induced cardiovascular
reactivity and improvements in rated sleep. In addition, Kondo, Nomura, Nakaya, Ito and
Ohguro (2005) studied the association of hs-CRP with aerobic exercise capacity,
maximum oxygen uptake and insulin resistance in 50 healthy subjects. They used a
multi-step treadmill exercise test to attain the maximum oxygen uptake. Their results
suggest that the development of exercise habits increases the maximum oxygen uptake,
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thereby reducing the inflammatory marker hs-CRP. Therefore, the relationship of
exercise on stress can be beneficial and may have influenced the inflammatory response
in individuals who participated in a regular exercise program.
The results of this study confirmed an association between increased hs-CRP
levels and overweight and obese individuals. The linkage confirms the seriousness of
overweight and obese states. These states have shown to produce many disease processes
such as diabetes, reproductive complications and urinary problems. The issue of
increased inflammation as indicated by elevated hs-CRP levels also shows the
relationship of overweight and obese states with heart disease.
Eleven subjects (18%) had hs-CRP levels of three or above which is considered to
be high risk according to the Centers for Health Promotion and Prevention and the
American Heart Association (2003). Reducing BMI and body fat even by a few points
move an individual from the obese to the overweight category, and can significantly
improve an individuals hs-CRP levels as a result. The mean hs-CRP levels for the
overweight category were 1.1 (SD=1.1) and the obese were 2.3 (SD=1.8) (p=.002). The
obese subjects were not in the high risk category of hs-CRP levels which is probably due
to the younger age of the study population, however, values are double that of those in
the overweight category.
The lack of a relationship between chronic stresses of daily life and hs-CRP levels
in overweight and obese males points to the need for further research on psychological
stress and inflammation. Differences between acute stressors and chronic stressors,
depressive mood and chronic stress, and mechanisms that regulate each need to be
investigated.
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B. Strengths and Limitations
This study was based on a sound instruments. The methodology included
validated measures of psychological stress (Cohen, Tyrrell & Smith, 1993), body mass
index, body fat percentage and hs-CRP. The use of tools and methods that have been
validated and used for years, increases the likelihood that variables were measured
accurately and appropriately. The Perceived Stress Scale has been used in research that
links perceived stress with bacterial vaginosis during pregnancy, inflammatory bowel
disease and avoidance in pseudoseizures (Culhane, et ah, 2001; Frances, Baker &
Appleton, 1999; Sewitch, et ah, 2001). The PSS has been used as the tool to assess
perceived stress under differing situations and has proven to be a valid instument. The
hs-CRP test is also a validated measurement used in the clinical setting and
recommended by the Centers for Disease Control and Prevention and the American Heart
Association (2003) as an assessment tool to evaluate heart disease risk. Errors were also
reduced because measurements were taken and recorded immediately. For example,
blood testing was completed within two hours of each blood draw, which reduced
possible errors caused by standing blood and errors in paperwork.
The present study was also based on logical assumptions of similar relationships
between acute stress and depression with increased hs-CRP levels. The investigation of a
correlation between chronic stress and increased hs-CRP levels in overweight and obese
males was based on previous research conducted on acute stressors and depression.
Acute stressors (Dugue, Leppaen, Teppo, Fyhrquist & Grasbeck, 1993; Melamed,
Shirom, Toker, Berliner & Shapira, 2004) and depression (Ladwig, et ah, 2003) were
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related to increased hs-CRP levels; therefore, a possible correlation between chronic
stress and increased hs-CRP was deemed reasonable.
When setting up the study design, a medium effect size was assumed, based on
previous literature. Therefore, a sample size of 60 subjects was calculated based on a
power analysis of 80%, alpha=0.05, and an expected correlation between CRP and stress
levels of at least r=.30. However, the low power used in the study does not allow for the
detection of small effect sizes such as those found. Using Spearman’s rho, assuming a
small effect size of .06, the study would have had to test 1,050 subjects to reach
significance. Using Pearson’s correlation coefficient for a small effect size of .10, 400
subjects would have been needed.
The time of testing differed for each subject, which may have affected hs-CRP
levels. CRP possesses an even half-life and stays constant around 19 hours under all
conditions (Hirschfield & Pepys, 2003); therefore, it is unlikely that the time of day
influenced the results. However, times of collection varied from 8 am to 10 pm, and
time of blood draw may prove to be a factor in further research.
Another limitation of the study was the narrow range of hs-CRP levels found,
which ranged from .30 to 5.54 with 11 (18.3%) being high risk. This study had lower hs-
CRP values compared to the Ladwig et al. study, which had a broader range of hs-CRP
levels and was probably due to differences in age which may have allowed for the
detection. Another factor that limited the study was the restriction of age. Subjects were
included in the study only if they were 20 to 35 years old, whereas Ladwig et al. (2003)
studied men ages 45-74 (x=58.3). This criterion limited the generalization of results to
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only this younger age group, which may not exhibit enough of an inflammatory response
to stressors.
Another possible limitation to the study may have been the use of the Perceived
Stress Scale as the tool for assessing psychological stress. It was a tool created in the
1980s, and has been validated with coefficient alphas in a .84-.86 range. It has been used
many times by its author, Cohen, and by others, and consistently found to be associated
with inflammatory bowel disease and immune-inflammatory changes. Maes, et al.
(1999) used the PSS to test 38 university students to determine that academic
examination of stress created changes in the distribution of peripheral blood mononuclear
cells, indicating immune activation, which is assumed to be orchestrated by stress-
induced production of cytokines. In addition, Sewitch, et al. (2001) used the PSS with
200 patients and found that strategies aimed at improving social support can have a
positive impact on psychological distress, which improved health outcomes for these
patients with inflammatory bowel disease. The PSS was also used by Song, et al. (1999),
who studied 38 university students and concluded that psychological stress induces
immune-inflammatory changes pointing toward complex regulatory responses in IL-6
signaling, a decreased anti-inflammatory capacity of blood serum and interactions with T
cell and monocyte activation. The use of the PSS in these studies show that the
instrument is an appropriate tool because of its reliability and validity in similar research
on biopsychosocial outcomes including immune parameters.
The main limitation of this study was the use of a cross-sectional design. This
type of study design cannot demonstrate causation, if an association of PSS and hs-CRP
exists. Nevertheless, it provides preliminary evidence that stress, as measured by the
53
Perceived Stress Scale, does not appear to be directly related to hs-CRP in young,





High sensitivity CRP has become a popular topic in clinical practice over the
past few years. Currently hs-CRP testing is not a standard practice in the clinical setting
(AHA & CDCP, 2003). The strength of hs-CRP testing in contributing to the diagnosis
of heart disease and predicting future cardiac events remains to be seen. However,
current studies show that hs-CRP is a beneficial test to run separately or in conjunction
with total cholesterol levels (AHA & CDCP, 2003). The use of this inflammatory marker
as an accepted clinical tool is promising. One of the purposes of this study was to
determine if a psychological factor, stress might be associated with this inflammatory
marker in an attempt to strengthen the argument that hs-CRP testing is vital in the
prevention and detection of heart disease. The following is a list of study conclusions:
Body mass index and body fat percentage are highly correlated with1.
elevated hs-CRP levels.
Chronic stress of daily life is not linearly associated with hs-CRP levels in2.
young, otherwise healthy overweight and obese men.
Health status is negatively associated with body fat, BMI and hs-CRP;3.




An association between chronic psychological stress and CRP was not found
in this study. (See Appendix F) Therefore, further investigation needs to be done on this
topic using a larger sample size in order to uncover possible smaller associations if they
exist. Chronic psychological stress did not produce an inflammatory response in either
overweight or obese males, indicating possible mechanism differences between chronic
and acute stress. The following questions are posed for future research in this area:
Does the severity of the negative psychological state, such as stress, affect the1.
amount and type of inflammation in the body?
Does length of time (acute versus chronic) of negative psychological state, such2.
as stress, affect the amount and type of inflammation in the body?
Does exercise status affect stress and inflammation levels in the overweight and3.
obese? In addition, does exercise affect coping mechanisms thereby influencing
inflammatory responses?
What is unique about the association of hs-CRP to depressive mood and acute4.
psychological stress that is different from chronic stress as measured by PSS?
How much does coping style influence hs-CRP levels in overweight and obese5.
men? Does the way an individual perceives and manages stress influence the
bodily response to stressful situations?




Although there was no association found between chronic stresses of daily life
and hs-CRP levels in young overweight and obese men, there are applications to clinical
practice that can be recommended. Obesity clearly must be targeted as a condition that
increases inflammation and in turn, heart disease. Obesity is associated with many
disease processes (Neilson & Schneider, 2005); however, the hs-CRP test can be used to
uncover increased risk of heart disease or future coronary events above and beyond
traditional risk factors, especially among overweight and obese individuals. Laimer, et
al. (2005), showed that weight loss is associated with a pronounced decrease in non-
traditional cardiovascular risk markers such as hs-CRP. Therefore, health education can
then be used to discuss exercise and nutrition strategies to decrease body fat with the
ultimate goal of decreasing risk of heart disease.
This study also showed that body fat percentage influences an individual’s
perceived health status. A negative association between body fat percentage and
perceived health status was found (r=-.361). Health status was not correlated with hs-
CRP, when controlling for body fat percentage r=-.08 (p=.54), but body fat percentage
and health status were correlated (r=. 30, p=.02), when controlling for hs-CRP. The
implications of these results show that self-perception of health status and body fat can be
targeted in health education. Therefore, issues concerning body fat arise again as areas
that need to be targeted by preventive care efforts.
The association between the mind and the body is a powerful relationship. The
mechanisms that govern these reactions are still largely unknown. As research and
knowledge increase, more aspects of these mechanisms will be understood. Studies such
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as this provide information concerning the mind-body linkage and contribute to the quest
for understanding this complex relationship. The present study attempted to uncover
another psychological state that might be associated with increased hs-CRP levels in
overweight and obese males. However, the results of this study found no association,
pointing to the need for further investigation of other unknown mechanisms and
characteristics involved between psychological states and the inflammatory system.
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By joining this study you will receive:
❖ FREE body mass index and body fat assessment
❖ FREE blood pressure testing
❖ FREE high sensitivity C-reactive protein (CRP) blood 
test assessing atherosclerotic risk
Requirements for study:
❖ Healthy male
❖ 20-35 years old
❖ ABOVE normal weight
Study procedures will involve:
❖ About 30 minutes of your 
time
❖ A blood draw of about 1 tsp 
of blood
❖ Height, weight, blood pressure 
and body fat assessment
♦> Completing a short survey
RESULTS WILL BE COMPLETELY CONFIDENTIAL
(Loma Linda University School of Public Health Dissertation Study)
(909) 799-6613 orFOR MORE INFORMATION CALL:
email:olivialm@verizon.net
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Paycheck Stuffer
Research Project: C-reactive Protein
You are invited to participate in a dissertation research project with the School of Public 
Health. The project is investigating the relationship of psychological stress to C-reactive 
protein (CRP) levels in overweight and obese men. Participants will receive free CRP, 
blood pressure and body composition testing. C-reactive protein testing is associated 
with the detection of atherosclerosis. Participants must be healthy males between 20 to 
35 years of age, above normal weight, and have not taken anti-inflammatory medication 
within 48 hours of testing. Testing session will last approximately 30 minutes. For more 
information and if you are interested, contact Olivia Moses of the school of public health 
at (909) 799-6613.
Telephone Script
Hello, thank you for your interest in our research study. C-reactive protein is a biomarker 
for inflammation and can be used as an indicator for atherosclerosis or atherosclerotic 
risk. We are looking for people that fit certain criteria. Can I ask you a few questions? 
What is your height and weight? Are you on any medications such as Ibuprofen, 
Naproxen, prescription NSAEDS or aspirin?
If participant fits criteria: I would be delighted if you would be willing to participate in 
this study. When you come to the Center for Health Promotion located on the comer of 
Anderson and Stewart Street you will be given material describing the study and also be 
given a chance to ask any questions. You will be given a one page questionnaire with 10 
questions and you will have your blood pressure taken. You will then have your height 
and weight measured and your body fat tested. Next, you will have your blood drawn. 
CRP testing only requires one teaspoon of blood, therefore, it is a quick procedure. In 
addition, CRP testing is not associated with food intake so please feel free to eat before 
testing. The whole session should take approximately 30 minutes. Do you have any 
questions about the study or its procedures? Can I set you up with a time slot for you to 
come to the Center for Health Promotion? If you know of anyone else that would fit the 
criteria and would be willing to participate please have them contact me for more 
information. I am very thankful to you for your participation in this study and your part 
in helping me obtain my doctoral degree.
If participant does not fit criteria: Unfortunately, for this purposes of this particular 
study you do not fit the criteria. However, if you are interested in C-reactive protein and 
its role in atherosclerosis you are welcome to come to the Center for Health Promotion 
during the times of testing to receive a free informational hand-out. Thank you for 





The questions in this scale ask you about your feelings and thoughts during the Last
month. In each case, you will be asked to indicate by circling how often you felt or 
thought a certain way.
DateName
OtherGender (Circle): M FAge
0 = Never 1 = Almost Never 2 = Sometime 3 = Fairly Often 4 = Very Often
1. In the last month, how often have you been upset 
because of something that happened unexpectedly? 0 12 3 4
2. In the last month, how often have you felt that you were unable 
to control the important things in your life?................................ 0 12 3 4
3. In the last month, how often have you felt nervous or “stressed”?....0 12 3 4
4. In the last month, how often have you felt confident 
about your ability to handle your personal problems? 0 12 3 4
5. In the last month, how often have you felt that things 
were going your way?................................................. 0 12 3 4
6. In the last month, how often have you found that you 
could not cope with all the things that you had to do? 0 12 3 4
7. In the last month, how often have you been able 
to control irritations in your life?....................... 0 12 3 4
8. In the last month, how often have you felt that you were 
on top of things?............................................................... 0 12 3 4
9. In the last month, how often have you been angered 
because of things that were outside of your control? 0 12 3 4
10. In the last month, how often have you felt difficulties 








1. In the last month have you experienced or been diagnosed with any of the 
following conditions? Check all that apply.




| In Common cold 
I If Gingivitis (gum disease)
I If Heart attack 
I ]g Major trauma 
specify)__________________
| 1H Mucosal infection (e.g.,
I li Pancreatitis 
I [j Rheumatic disease 
I Ik Seizures 
I lr. Stroke
| |m Systemic vasculitis 
| In Other (please
2. How often do you engage in vigorous physical activity for at least 20 minutes?
Check one.
I In Rarely or never 
| li Less than once per week 
I I?, Once per week
I h 2-3 times per week 
I L 4-5 times per week 
I Is 6+ times per week
3. How often do you engage in mild or moderate physical activity for at least 20 
minutes? Check one.
I lo Rarely or never 
| li Less than once per week 
I I? Once per week
I h 2-3 times per week 
I L 4-5 times per week 
| [5 6+ times per week
4. What medications are you currently taking (within the past 48 hours)? Check all 
that apply.
I L Aspirin
I |r Ibuprofen (e.g., Advil, Motrin)
I It Naproxen (e.g., Anaprox, Naprosyn)
I In Prescription NSAIDS (e.g., Celebrex, Vioyx)
I If Other over-the-counter medications (please specify)______________________
I If Other prescription medications (please specify)_________________________
5. What is the highest level of education you have achieved? Check one.
I li Below high school O2 High school College [3i Post-graduate
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6. How often have you attended religious services in the past month? Check one.
I k Once per week 
| [4 More than once per week 
| I5 Every day or almost every day
I lo Not at all
I li Once per month 
| 1? 2-3 times per week
7. On average, how many hours of sleep do you get in a 24-hour period? 
hours
8. How would you currently rate your health? Check one.
I l? Fair O3 Good O* Very good | |,s Excellent□1 Poor
9. What is your age? years
DateInvestigator Use Only 
of testing:___/_____/
Weight:inches lbs BMI:Height:___
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This study was reviewed and approved administratively on behalf of the IRB. This decision includes the 
following determinations:
1. Risk to research subjects: Minimal
2. Approval period begins 10/13/2004 and ends 10/12/2005.
3. Stipulations of approval are: <None Speclfied>
Consent Form
If a written consent form is required, approval will be indicated by the affixed IRB approval stamp. This 
now becomes your official consent form for the dates specified and should be used as a master for 
making the necessary copies.
Adverse Events / Protocol Changes
The IRB should be notified in writing of any modifications to the approved research protocol. All adverse 
effects, anticipated or not, should be reported to the IRB: serious events should be reported within seven 
days; all others within 15 days.
Protocol Review
To assure uninterrupted approval of this project, you are required to complete and return a status report 
at least two weeks prior to the approval end-date indicated above. (See http://research.llu.edu - select 
"IRB Tools for Investigators", then "Research Report Form.") In addition to requesting a renewal, you 
may also use the Research Report Form to close the study.
Records
All records relating to this project, including signed consent forms, must be kept on file for three years 
following completion of the study.
Please note the Pi's name and the OSR number assigned your IRB application (as indicated 
above) on any future communications with the IRB about this project. Direct all communications 
to the IRB do the Office of Sponsored Research.
Thank you for your cooperation in LLU's shared responsibility for the ethical use of human subjects in research
Signature of IRB Chair/Designee:.
Loma Linda University Adventist Health Sciences Center holds Federalwide Assurance (FWA) No. 6447 with the U.S. Office for Human Research Protections, and the 
IRB registration no. Is IORG226. This Assurance applies to the following institutions: Loma Linda University. Loma Unda University Medical Center (Including Loma 
Linda University Children's Hospital. LLU Community Medical Center), Loma Linda University Behavioral Medicine, and affiliated medical practices groups.
IRB Administrator
Linda G. Halstead, M.A., Director
Office of Sponsored Research
Ext. 43570, Fax 80131, lhalstead@univ.llu.edu
IRB Chair:




Obed B Rutebuka, PhD
Office of Sponsored Research




Loma Linda, California 92350 
(909)558-4546 
FAX: (909) 558-4087
School of Public Health
Title of Study: The relationship of psychological stress to c-reactive protein (hs-CRP) levels in men
Purpose of Study:
The purpose of this study is to examine the relationship of stress to C-reactive protein (CRP) levels in 
males who are above normal weight CRP level is an indicator of inflammation, which is linked to coronary 
artery disease. This study is being used as the dissertation project for Olivia Moses in partial fulfillment of her 
Doctor of Public Health degree in the Loma Linda University School of Public Health.
Description and Procedures:
If you agree to participate, the following procedures will be performed in the order listed:
(1) Complete a short questionnaire on physical activity, medication use, and other lifestyle factors.
(2) Psychological stress levels will be assessed by completing a short, 10-item questionnaire.
(3) Height and weight will be measured in order to calculate your body mass index (BMI).
(4) Body fat percentage will be assessed using a hand-held bioimpedence machine. This machine 
sends a small electric current through the hands and results are based on the principal that body fat 
conducts electricity different than body muscle.
(5) Approximately 1 teaspoon of blood will be drawn from the vein in your arm. This will be analyzed 
in tire following week to determine your CRP level. You will receive the results of this test within 
two weeks of your participation, via a telephone call from Olivia Moses. If your CRP level is at or 
above the level determined to be high risk, you will be referred to your primary care physician or 
student health services for a second CRP test and follow-up.
These procedures will take about 30 minutes.
Risks:
The blood draw may produce discomfort, pain, fainting or feeling lightheaded, infection, bruising, or 
swelling at the site. A certified phlebotomist will perform the blood draw using a sterile needle and standard 
blood draw techniques, and apply pressure to the site to reduce bruising. There is no known risk involved with 
bioimpedence machine used to determine your body fat percentage. The committee at Loma Linda University 
that reviews human studies (Institutional Review Board) has determined that participation in this study poses 
minimal risk.
Benefits:
By participating in this research, you will help contribute to a scientific understanding of the potential 
relationship of stress to CRP levels, a marker for coronary artery disease. You will receive the results of the 
CRP blood test, body mass index calculation, and body fat testing.
Confidentiality:
All information gathered will be used for this study only, to increase knowledge of the effects of stress 
on CRP levels. Once all subjects have received their CRP blood test results, names and other identifying 
information will be stripped from the data in order to protect tire confidentiality of results.
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Participation and Withdrawal:
Your participation in this research project is completely voluntary. You have the right at ANY time to 
withdraw from this research study.
Contact Persons:
If you have any questions please feel free to ask them at any time. Please contact Olivia Moses at (909) 
799-6613 or Dr. Helen Hopp Marshak at (909) 558-4741 in the Health Promotion and Education Department in 
the Loma Linda University School of Public Health. If you wish to contact an impartial third party not 
associated with this study regarding any questions or complaints you may have about the study, please contact 
the Office of Patient Relations, Loma Linda University Medical Center, Loma Linda, CA 92350, phone (909) 
558-4547.
Informed Consent Statement:
"/ have read the contents of the consent form and have listened to the verbal explanation given by the 
investigator. My questions concerning this study have been answered to my satisfaction. I hereby give voluntary 
consent to participate in this study. Signing this consent document does not waive my rights nor does it release 
the investigators, institution or sponsors from their responsibilities. I may call Dr. Helen Hopp Marshak during 
routine office hours at (909) 558-4741if I have additional questions or concerns."
"I have been given a copy of this consent form."
Sign Name Date
Witness Signature Date
"I have reviewed the contents of this consent form with the person signing above. I have explained potential 
risks and benefits of the study."
Investigator Signature Phone: (909)799-6613 Date
10MH LINDA UNIVERSITY
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Inflammation, Heart Disease and Stroke: The Role of C-
Reactive Protein
❖ How does inflammation relate to heart disease and stroke risk?
“Inflammation” is the process by which the body responds to injury. Laboratory 
evidence and findings from clinical and population studies suggest that inflammation 
is important in atherosclerosis (ath”er'0'skleh'RO’sis). This is the process in which 
fatty deposits build up in the lining of arteries.
Oreactive protein (CRP) is one of the acute phase proteins that increase during 
systemic inflammation. It’s been suggested that testing CRP levels in the blood may be 
a new way to assess cardiovascular disease risk. A high sensitivity assay for CRP test 
(hs-CRP) is now widely available.
The American Association and the Centers for Disease Control and Prevention 
recently published a joint scientific statement about using inflammatory markers in 
clinical and public health practice. This statement was developed after systematically 
reviewing the evidence of association between inflammatory markers (mainly CRP) 
and coronary heart disease and stroke.
WhaTs the role of CRP in predicting recurrent cardiovascular and 
stroke events?
A growing number of studies have examined whether hs-CRP can predict 
recurrent cardiovascular disease and stroke and death in different settings. High levels 
of hs-CRP consistently predict new coronary events in patients with unstable angina 
and acute myocardial infarction (heart attack). Higher hs-CRP levels also are 
associated with lower survival rate of these people. Many studies suggested that after 
adjusting for other prognostic factors, hs-CRP was still useful as a risk predictor.
Recent studies also suggest that higher levels of hs-CRP may increase the risk that 
an artery will reclose after it’s been opened by balloon angioplasty. High levels of hs- 
CRP in the blood seem to predict prognosis and recurrent events in patients with 
stroke and peripheral arterial disease.
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❖ What’s the role of hs-CRP in predicting new cardiovascular 
events?
Most studies show that the higher the hs-CRP levels, the higher the risk of 
developing heart attack. In fact, scientific studies have found that the risk for heart 
attack in people in the upper third of hs-CRP levels is twice that of those whose hs- 
CRP is in the lower third. These prospective studies include men, women and the 
elderly. Recent studies also found an association between sudden cardiac death, 
peripheral arterial disease and hs-CRP. However not all of the established 
cardiovascular risk factors were controlled for when the association was examined. 
The true independent association between hs-CRP and new cardiovascular events 
hasn’t yet been established.
❖ What is the normal range of hs-CRP level?
1. If hs-CRP level is lower than 1.0 mg/L, a person has a low risk of 
developing cardiovascular disease.
2. If hs-CRP is between 1.0 and 3.0 mg/L, a person has an average risk.
3. If hs-CRP is higher than 3.0 mg/L, a person is at high risk.
4. If, after repeated testing, patients have persistently unexplained, 
markedly elevated hs-CRP (greater than 10.0 mg/L), other evaluation 
should be considered to exclude noncardiovascular causes.
www.americanheart.org
If you fall into categories described in numbers 3 or 4 
above please contact your primary care physician 







Research Project: C-reactive Protein
You are invited to participate in a dissertation research project with the School of Public 
Health. The project is investigating the relationship of psychological stress to C-reactive 
protein (CRP) levels in overweight and obese men. Participants will receive FREE 
CRP, blood pressure and body composition testing. C-reactive protein testing is 
associated with the detection of atherosclerosis. Participants must be healthy males 
between 20 to 35 years of age, above normal weight, and have not taken anti­
inflammatory medication within 48 hours of testing. Testing session will last 
approximately 15 minutes. For more information and if you are interested, contact Olivia 
Moses of the school of public health at (909) 799-6613.
Location: Center for Health Promotion (Student Health in Evans Hall) on the Comer of 




Scatter Plot of PSS Scores and High Sensitiviy CRP Levels
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